Indirect intracranial volume measurements using CT scans: clinical applications for craniosynostosis.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMID 1727261)

Published in Plast Reconstr Surg on January 01, 1992

Authors

J C Posnick1, U Bite, P Nakano, J Davis, D Armstrong

Author Affiliations

1: Craniofacial Program, Hospital for Sick Children, Toronto, Ont., Canada.

Articles by these authors

(truncated to the top 100)

The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14

Mycobacterium avium complex infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 6.79

Effect of a general practitioner's consulting style on patients' satisfaction: a controlled study. BMJ (1990) 6.15

Outcome of acetaminophen overdose in pediatric patients and factors contributing to hepatotoxicity. J Pediatr (1997) 5.47

Infections caused by Mycobacterium avium complex in immunocompromised patients: diagnosis by blood culture and fecal examination, antimicrobial susceptibility tests, and morphological and seroagglutination characteristics. J Clin Microbiol (1985) 5.22

Referral to hospital: perceptions of patients, general practitioners and consultants about necessity and suitability of referral. Fam Pract (1987) 5.11

Mutation of the Angelman ubiquitin ligase in mice causes increased cytoplasmic p53 and deficits of contextual learning and long-term potentiation. Neuron (1998) 4.92

Comparison of criteria derived by government and patients for evaluating general practitioner services. BMJ (1989) 4.36

Fungemia in the immunocompromised host. Changing patterns, antigenemia, high mortality. Am J Med (1981) 4.31

Infection in total knee replacement: a retrospective review of 6489 total knee replacements. Clin Orthop Relat Res (2001) 4.15

Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.02

Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Infect Dis (1985) 4.00

Diaphragm function and alveolar hypoventilation. Q J Med (1976) 3.94

Aspergillosis complicating neoplastic disease. Am J Med (1973) 3.80

Diagnostic criteria for Walker-Warburg syndrome. Am J Med Genet (1989) 3.74

Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation. BMJ (1999) 3.62

Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoites. Nature (1987) 3.51

An evidence-based approach to the management of uninvestigated dyspepsia in the era of Helicobacter pylori. Canadian Dyspepsia Working Group. CMAJ (2000) 3.45

The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal. Ann Rheum Dis (2009) 3.32

Imprinted expression of the murine Angelman syndrome gene, Ube3a, in hippocampal and Purkinje neurons. Nat Genet (1997) 3.32

Consensus statement on the live organ donor. JAMA (2000) 3.29

Human immunity to Pseudomonas aeruginosa. I. In-vitro interaction of bacteria, polymorphonuclear leukocytes, and serum factors. J Infect Dis (1972) 3.28

Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med (1994) 3.25

Effect of community-based interventions on high-risk drinking and alcohol-related injuries. JAMA (2000) 3.24

Continuous high-grade mycobacterium avium-intracellulare bacteremia in patients with the acquired immune deficiency syndrome. Am J Med (1985) 3.19

A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal (1996) 3.18

Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 3.17

Reasons for referral to hospital: extent of agreement between the perceptions of patients, general practitioners and consultants. Fam Pract (1986) 3.14

Comparative recovery of bacteria and yeasts from lysis-centrifugation and a conventional blood culture system. J Clin Microbiol (1983) 3.09

Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (1997) 3.06

A reevaluation of cancer incidence near the Three Mile Island nuclear plant: the collision of evidence and assumptions. Environ Health Perspect (1997) 3.04

Investigation of burnout in a sample of British general practitioners. Br J Gen Pract (1995) 3.03

Intraorbital wood. Detection by magnetic resonance imaging. Ophthalmology (1990) 2.99

Bacteremia and fungemia complicating neoplastic disease. A study of 364 cases. Am J Med (1977) 2.92

Measuring general practitioner referrals: patient, workload and list size effects. J R Coll Gen Pract (1988) 2.91

International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis. Ann Rheum Dis (2003) 2.85

The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther (2003) 2.83

Bronchoalveolar lavage in the diagnosis of diffuse pulmonary infiltrates in the immunosuppressed host. Ann Intern Med (1984) 2.80

The biochemical basis of nitroblue tetrazolium reduction in normal human and chronic granulomatous disease polymorphonuclear leukocytes. Blood (1976) 2.76

Brain spectrin, a membrane-associated protein related in structure and function to erythrocyte spectrin. Nature (1982) 2.74

Prospective study of outcome in antenatally diagnosed renal pelvis dilatation. Arch Dis Child Fetal Neonatal Ed (1999) 2.73

Fatal injuries to bicyclists: the experience of Dade County, Florida. J Trauma (1983) 2.73

Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis. Pediatr Pulmonol (1999) 2.73

Species identification of coagulase-negative staphylococcal isolates from blood cultures. J Clin Microbiol (1982) 2.71

Preferences of healthy and ill patients for style of general practitioner care: implications for workload and financial incentives under the new contract. Br J Gen Pract (1991) 2.66

Genetic linkage of hyper-IgE syndrome to chromosome 4. Am J Hum Genet (1999) 2.63

Telephone consultations in general practice: an additional or alternative service? Br J Gen Pract (1995) 2.62

Ankyrin and spectrin associate with voltage-dependent sodium channels in brain. Nature (1988) 2.60

Tobramycin (nebramycin factor 6): in vitro activity against Pseudomonas aeruginosa. Appl Microbiol (1971) 2.60

Septicemia due to Aeromonas hydrophila: clinical and immunologic aspects. J Infect Dis (1973) 2.55

Oxidative damage to DNA in diabetes mellitus. Lancet (1996) 2.54

Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis (1990) 2.51

Patients' responses to risk information about the benefits of treating hypertension. Br J Gen Pract (2001) 2.50

Patients' views of priority setting in health care: an interview survey in one practice. BMJ (1995) 2.50

Voltage-activated calcium channels that must be phosphorylated to respond to membrane depolarization. Proc Natl Acad Sci U S A (1987) 2.48

Fulminating vibrio parahemolyticus septicemia. A syndrome of erythemia multiforme, hemolytic anemia, and hypotension. Arch Intern Med (1974) 2.46

Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency. Ann Intern Med (1982) 2.41

The role of superoxide anion and hydrogen peroxide in phagocytosis-associated oxidative metabolic reactions. J Clin Invest (1975) 2.40

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis (1990) 2.39

Tuberculosis complicating neoplastic disease. A review of 201 cases. Cancer (1974) 2.36

High frequency of antimicrobial resistance in human fecal flora. Antimicrob Agents Chemother (1988) 2.30

Changes in bone mineral content in male athletes. Mechanisms of action and intervention effects. JAMA (1996) 2.29

Pneumothorax in AIDS. Ann Intern Med (1991) 2.29

Candidiasis: detection by gas-liquid chromatography of D-arabinitol, a fungal metabolite, in human serum. Science (1979) 2.26

Nocardia asteroides infection complicating neoplastic disease. Am J Med (1971) 2.23

Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med (1993) 2.22

First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis (2005) 2.21

Abnormalities of thyroid function in infants with Down syndrome. J Pediatr (1984) 2.19

The prevalence of yeasts in clinical specimens from cancer patients. Am J Clin Pathol (1980) 2.19

Functional conservation of atonal and Math1 in the CNS and PNS. Development (2000) 2.18

Phycomycosis complicating leukemia and lymphoma. Ann Intern Med (1972) 2.17

Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection. J Infect Dis (1982) 2.16

Nude mouse: a new experimental model for Pneumocystis carinii infection. Science (1977) 2.16

1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clin Infect Dis (1997) 2.14

Multiorgan autonomic dysfunction in mice lacking the beta2 and the beta4 subunits of neuronal nicotinic acetylcholine receptors. J Neurosci (1999) 2.12

Interaction of spontaneous respiration with artificial ventilation in preterm babies. J Pediatr (1983) 2.11

Clinical spectrum of infection due to Bacillus species. Am J Med (1973) 2.11

Autooxidation as a basis for altered function by polymorphonuclear leukocytes. Blood (1977) 2.10

Complement-fixation tests with cell lines derived from Burkitt's lymphoma and acute leukemias. J Bacteriol (1966) 2.10

Comparative recovery of fungi from biphasic and conventional blood culture media. J Clin Microbiol (1981) 2.09

Invasive aspergillosis. Progress in early diagnosis and treatment. Am J Med (1981) 2.07

In vitro activity of the new semi-synthetic polypeptide cilofungin (LY121019) against Aspergillus and Candida species. Eur J Clin Microbiol Infect Dis (1990) 2.06

Patterns of work in general practice in the Bromley health district. J R Coll Gen Pract (1987) 2.05

PCV-2 genotype definition and nomenclature. Vet Rec (2008) 2.04

Mycobacterium haemophilum: microbiology and expanding clinical and geographic spectra of disease in humans. Clin Microbiol Rev (1996) 2.04

Urinary diagnosis of gonorrhoea and Chlamydia in men in remote aboriginal communities. Med J Aust (1997) 2.01

Guidelines for reporting clinical features in cases with MECP2 mutations. Brain Dev (2001) 1.99

Bacterial pneumonia in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1986) 1.99

The patient's view. Soc Sci Med (1984) 1.97

Detection of HIV-1 DNA sequences in pre-ejaculatory fluid. Lancet (1992) 1.93

Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr Infect Dis J (1996) 1.93

Low-molecular- weight Rauscher leukemia virus protein with preferential binding for single-stranded RNA and DNA. J Virol (1976) 1.92

Visual cortical mechanisms detecting focal orientation discontinuities. Nature (1995) 1.92

Cryptosporidium and cryptosporidiosis. Rev Infect Dis (1987) 1.91

The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol (2000) 1.91

Access to specialist gastroenterology care in Canada: comparison of wait times and consensus targets. Can J Gastroenterol (2008) 1.89

What do patients want? BMJ (1991) 1.85

Vitamin E protects nerve cells from amyloid beta protein toxicity. Biochem Biophys Res Commun (1992) 1.85

Tuberculosis in the AIDS era. Clin Microbiol Rev (1995) 1.85